Valion Bio (VBIO) Assets Average (2022 - 2026)

Valion Bio's Assets Average history runs 4 years deep, the most recent figure standing at $18.9 million for Q4 2025.

• In Q4 2025, Assets Average rose 510.16% year-over-year to $18.9 million; the TTM figure through Dec 2025 stood at $18.9 million (up 510.16% YoY), while the FY2025 annual figure was $17.2 million, up 332.12% from the prior year.
• Assets Average for Q4 2025 stood at $18.9 million, up from $5.4 million in the prior quarter.
• The five-year high for Assets Average was $18.9 million in Q4 2025, with the low at $3.1 million in Q4 2024.
• The 4-year median for Assets Average is $5.8 million (2023), against an average of $7.1 million.
• The sharpest annual moves came in 2023 and 2025: Assets Average plunged 53.21% in 2023, then jumped 510.16% in 2025.
• Valion Bio's Assets Average stood at $7.0 million in 2022, then fell by 13.63% to $6.1 million in 2023, then plunged by 49.02% to $3.1 million in 2024, then surged by 510.16% to $18.9 million in 2025.
• Business Quant data shows VBIO's Assets Average at $18.9 million in Q4 2025, $5.4 million in Q3 2025, and $4.1 million in Q2 2025.